SynthesisFrontiers in oncology2025

Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings.

Armen Aprikian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.